期刊
BIOMOLECULES
卷 12, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/biom12050711
关键词
nanobodies; pancreatic cancer; patient derived orthotopic xenograft; CEA; fluorescenceguided-surgery; fluorescence; near-infrared; IRDye800CW; tumor labeling
资金
- National Institute of Health [T32CA121938, R01CA256973]
- VA Merit review [1 I01 BX003856-01A1, 1 I01 BX004494-01]
Tumor-specific targeting can be enhanced with fluorescent nanobodies, allowing for rapid localization and labeling of pancreatic cancer tumors. The fluorescence signal is durable, and both targeting and imaging can be performed on the same day as surgery.
Tumor-specific targeting with fluorescent probes can enhance contrast for identification of cancer during surgical resection and visualize otherwise invisible tumor margins. Nanobodies are the smallest naturally-occurring antigen-binding molecules with rapid pharmacokinetics. The present work demonstrates the efficacy of a fluorescent anti-CEA nanobody conjugated to an IR800 dye to target and label patient derived pancreatic cancer xenografts. After intravenous administration, the probe rapidly localized to the pancreatic cancer tumors within an hour and had a tumor-tobackground ratio of 2.0 by 3 h. The fluorescence signal was durable over a prolonged period of time. With the rapid kinetics afforded by fluorescent nanobodies, both targeting and imaging can be performed on the same day as surgery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据